Press Archive
Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast…
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.
Karen Lewis, PhD, director of administration of the Standardized Patient Program and the CLASS Center at GW School of Medicine and Health Sciences was awarded the ASPE Outstanding Educator of the Year Award.
In January 2017, the Society of Government Service Urologists awarded Harold Frazier, MD, professor of urology at the GW School of Medicine and Health Sciences, the Outstanding Service Award.
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.…
GW School of Medicine and Health Sciences is pleased to announce that Rea Childs will serve the school as HR director.
Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of patients’ risk for acute coronary syndrome (ACS), which includes heart attack, in patients of different gender and race.
Mathilde "Matty" Knight, PhD, adjunct professor of microbiology, immunology, and tropical medicine at GW School of Medicine and Health Sciences was on the research team that found a genome in the Biomphalaria snail that may explain why the snail is a prime transmitter for the parasite,…
The GW Cancer Center is pleased to announce the opening of the Supportive Oncodermatology Clinic. This clinic is the only one of its kind in the Washington, D.C. region, and one of only a handful of such clinics in the country.
Eduardo Sotomayor, MD, director of the GW Cancer Center, published research looking at the development of resistance to Ibrutinib, a drug used to treat patients suffering with mantle cell lymphoma.